29.1 Finance costs 250.93 403.07 (152.14) (37.7) Income tax expense 215.17 164.03 51.14 31.2 Total expenses 2,211.89 2,102.74 109.15 5.2 2,175.99 2,309.70 (133.71) (5.8) Non-controlling Interests - (3.04

51% 405 599 48% Cost of sales (68) (111) 63% (132) (210) 59% Gross Profit 138 201 46% 273 389 42% Other Income 3 3 0% 5 5 0% Selling and distribution expenses (68) (85) 25% (134) (160) 19

follow: Income statements Second Quarterly Operational Performance The Company reported Revenues from Hospital Operations of Baht 213.42 million, a 50.09% increase year-over-year from Baht 142.19 million

Baht 37.3 million. 4. Accrued income tax payable decreased Baht 1.7 million. 5. Long-term loans from financial institutions increased Baht 1,797.0 million. 6. Employee benefit obligations increased Baht

statements of profit or loss and other comprehensive income, the changes are as follows: - 1) The commission paid to obtain a customer contract shall be recorded as an asset and amortized to expenses on a

manufacture and 3rd party’s products for distribution prove their successfulness in generating incremental sales and gross profits to the Group, creating stable income sources with growth potential and

overdrawn amount 31 MB and settle the long-term loan to the financial institute in 1 year decreased 2 MB and increasing 4 MB from Income Tax Payable, decreased of the other liabilities 1 MB  Shareholders

customers decreased Baht 41.7 million. 4. Accrued income tax payable decreased Baht 26.6 million. 5. Long-term loans from financial institutions increased Baht 1,023.9 million. 6. Employee benefit obligations

, which exempts the corporate income tax for the revenue from the new factory, the tax expense decreased THB 3.46 million from the previous year. Therefore, the separate financial statements show a net

million Baht (52% of total revenues); slightly decreased by 10% as compared to Q1 2017 of 702 million Baht, (3) other income including trademark and trade name fees of DEAN & DELUCA of 58 million Baht (5